Neuroimaging of aggressive pituitary tumors

被引:0
作者
J. F. Bonneville
J. Potorac
A. Beckers
机构
[1] University of Liège,Department of Endocrinology and Medical Imaging CHU Sart Tilman
[2] University of Liège,Department of Endocrinology CHU Sart Tilman
来源
Reviews in Endocrine and Metabolic Disorders | 2020年 / 21卷
关键词
Pituitary tumors; Pituitary adenomas; Aggressiveness; MRI;
D O I
暂无
中图分类号
学科分类号
摘要
Aggresssive pituitary tumors are defined as radiologically invasive, exhibiting a rapid growth and a poor response to the medical and surgical treatment options. The role of magnetic resonance imaging (MRI) is fundamental to assess tumor aggressiveness before surgical exploration. Distinction between cavernous sinus invasion and cavernous sinus compression is often challenging and cannot be solved always by using the Knosp criteria. Ideally, T2W images demonstrating the ruptured internal dural wall of cavernous sinus is the ultimate proof of cavernous sinus invasion. Subtle tumor volume increase in a short time can be shown when sequential MR images are rigorously replicable. A microcystic pattern observed on T2W images frequently reflects a potentially aggressive tumor as observed in silent corticotroph pituitary adenomas.
引用
收藏
页码:235 / 242
页数:7
相关论文
共 49 条
[1]  
Cottier JP(2000)Cavernous sinus invasion by pituitary adenoma: MR imaging Radiology. 215 463-469
[2]  
Destrieux C(1993)Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings Neurosurgery. 33 610-617
[3]  
Brunereau L(2015)Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification Neurosurg 122 803-811
[4]  
Bertrand P(2013)Magnetic resonance imaging appearance of the medial wall of the cavernous sinus J Neuroradiol 40 245-251
[5]  
Moreau L(2017)Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading J Neurosurg 126 1714-1719
[6]  
Jan M(2019)A plea for the T2W MR sequence for pituitary imaging Pituitary 22 195-197
[7]  
Knosp E(2017)T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective Pituitary 20 116-120
[8]  
Steiner E(2010)Factors predicting relapse of nonfunctioning pituitary macroadenomas afterneurosurgery: a study of 142 patients Eur J Endocrinol 163 193-200
[9]  
Kitz K(2018)Silent corticotroph adenomas Pituitary. 21 183-193
[10]  
Matula C(2014)Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas Clin Endocrinol 81 566-572